Cargando...
Down-regulation of CD40 signal and induction of TGF-β by Phosphatidylinositol mediates reduction in immunogenicity against recombinant human Factor VIII
Factor VIII (FVIII) is an important coagulation cofactor and its deficiency causes Hemophilia A, a bleeding disorder. Replacement therapy using recombinant FVIII is currently the first line of therapy for Hemophilia A, but the development of neutralizing antibody is a major clinical complication for...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3996553/ https://ncbi.nlm.nih.gov/pubmed/21953409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.22746 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|